Fenlean

DESCRIPTION

Fenlean (FLZ) is currently conducting a phase I trial in the Institute of pharmacy, Chinese Academy of medical sciences as a potential treatment for Parkinson's disease.

DETAILS

Cas: 863193-70-8
Purity: 98%
Smiles: C(=CC1=CC(OC)=C(O)C=C1)(C(NCCC2=CC=C(O)C=C2)=O)C3=C(OC)C=CC(OC)=C3
Category: Compound
Molecular Weight: 449.5
Molecular Formula: C26H27NO6

Lead Time: 4 - 5 weeks